{"id":"W1989992323","doi":"10.1016/s0168-8278(11)61361-5","title":"1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE HCV G1/4 PATIENTS: INTERIM ANALYSIS FROM THE JUMP-C TRIAL","year":2011,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of British Columbia","funders":"","keywords":"Ribavirin; Medicine; Interim analysis; Virology; Interim; Internal medicine; Pharmacology; Clinical trial; Virus; Hepatitis C virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003795927,0.0009623005,0.002880006,0.0003082343,0.0003132728,0.00126656,0.0006274401,0.0008499273,0.004625909],"category_scores_gemma":[0.002708932,0.0004610333,0.004226279,0.0004267022,0.0005144523,0.0008245965,0.0004517996,0.002412619,0.0008942594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006996411,"about_ca_system_score_gemma":0.001130278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001119021,"about_ca_topic_score_gemma":0.002806125,"domain_scores_codex":[0.9985366,0.0008267617,0.00005870596,0.0001417968,0.000164844,0.0002712681],"domain_scores_gemma":[0.9978163,0.0009628378,0.0003455651,0.0003648365,0.0001032732,0.0004072002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.929575,0.00176522,0.01263716,0.000522439,0.007879932,0.0001549342,0.00006294691,0.005335985,0.004686607,0.0003014869,0.007365594,0.02971263],"study_design_scores_gemma":[0.6229457,0.1185796,0.211166,0.0002156287,0.02184258,0.0005194965,0.0001171524,0.007279209,0.007755568,0.001475583,0.007912723,0.0001908168],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9739938,0.003790117,0.001030949,0.000735298,0.0002230933,0.0004483243,0.01499943,0.0002052615,0.004573721],"genre_scores_gemma":[0.9789089,0.0006192029,0.000974043,0.0007697752,0.0001466942,0.0002927857,0.01523348,0.00006848884,0.002986568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004625909,"threshold_uncertainty_score":0.02007496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05552744191615485,"score_gpt":0.2987421881019374,"score_spread":0.2432147461857826,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}